ArticleNeurosurgery2021
Letter: A Phase II and Pharmacodynamic Trial of RO4929097 for Patients With Recurrent/Progressive Glioblastoma.
Abdur Rahman et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ArticleNeurosurgery2021
Abdur Rahman et al.PubMed ↗Publisher ↗
No numbers read from the abstract.